Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

People in their 50s are at higher amputation risk than older people after leg surgery

By: NewMediaWire

Research Highlights:

  • Adults in their 50s with peripheral artery disease or PAD — are more likely than adults older than 80 to undergo leg amputation one to five years after an emergency surgery to restore blood flow to the lower limbs.
  • This study analyzes outcomes among patients older than age 50 hospitalized with PAD, as noted in eight years of data collected in England.
  • Researchers say early diagnosis, risk factor modification and treatment are warranted to help prevent patients from developing severe forms of PAD.

Embargoed until 4 a.m. CT/5 a.m. ET Monday, July 22, 2024

(NewMediaWire) - July 22, 2024 - DALLAS — People in their 50s with severe peripheral artery disease or PAD may be more likely than people in their 80s to undergo leg amputation one to five years after emergency surgery to restore blood flow to the lower limbs, according to new research published today in the American Heart Association’s flagship journal Circulation.

Peripheral artery disease occurs when the arteries leading away from the heart narrow due to cholesterol deposits, preventing adequate blood flow throughout the body — commonly the lower extremities. The condition is estimated to affect 10 million to 12 million adults ages 40 and older in the U.S., according to 2024 guidelines from the American Heart Association and the American College of Cardiology.

Symptomatic PAD is characterized by painful muscle cramping in the hips, thighs, calves, or feet when walking, climbing stairs or exercising. The pain does not subside with rest. Modifiable risk factors for PAD include being a smoker, or former smoker, having diabetes, hypertension and/or abnormal cholesterol.

“People with severe forms of PAD requiring urgent surgery tend to have extremely poor disease progress. They are at high risk of limb loss and all-cause death following the initial surgery,” said study lead author Qiuju Li, Ph.D., a research fellow in medical statistics at the London School of Hygiene and Tropical Medicine in the United Kingdom. “Our primary finding is different from the traditional belief that older people were at an increased risk of major amputation. Our study, interestingly, shows the opposite relationship.”

This study analyzed previous data from nearly 95,000 adults older than age 50 with peripheral artery disease who had surgery to restore blood flow (known as revascularization) between 2013 and 2020 in England. The analysis projected the possibility of major limb amputation and death after revascularization. Major limb amputation was defined as leg amputation above the ankle.

Two-thirds of participants in the data review had undergone surgery to restore blood flow during an elective hospital admission, while the remainder had non-elective surgery during an emergency hospital admission. The analysis noted that:

  • The risk of major amputation among emergency admissions among patients between 50- to 54-years-old was 18% one year after revascularization and 28.8% five years after the surgery.
  • The risk of major amputation under the same circumstances for patients between ages 80 and 84-years-old was 11.9% at one year and 17% at five years.
  • Among patients who underwent a revascularization during an elective hospitalization, the risk of major amputation remained comparatively low regardless of the patient’s age: 10.8% for those 50- to 54-years-old, and 6.5% for those 80- to 84-years-old at five years.
  • However, the risk of death without a major amputation increased substantially among older patients after both elective and non-elective revascularizations: 48.7% and 58.9%, respectively, for patients between ages 80-84 at 5 years, vs. 12.9% and 16.9%, respectively, for those ages 50- 54 at 5 years.
  • After major amputation, the data showed participants were at an increased risk of death if they had undergone major amputation within six months of the revascularization.
  • More specifically, for participants between ages 80-84, the 1-year death rates after major amputation were 39.2% and 29.8% if they underwent major amputation at 3 months and 1 year, respectively, after revascularization, whereas the corresponding death rates were 20.3% and 14.9%, respectively, for those between ages 50 and 54.

“The findings also highlight how the association between the illness trajectories and patient characteristics is not straightforward,” Li said. “While being older at the time they had blood flow-restoring surgery was associated with a marked increase in the risk of death, the risk of major amputation after that surgery was lower among older patients rather than younger patients.”

In May 2024, joint guidelines from the American Heart Association, the American College of Cardiology and nine other medical societies highlighted the importance of early diagnosis and treatment to prevent amputation and other cardiovascular complications from lower extremity peripheral artery disease. The guidelines also called for coordinated care from a multispecialty team to treat the condition.

“This study shows that for patients with severe peripheral arterial disease, there is not one simple answer that can explain each patient’s condition,” said guidelines co-vice chair Philip Goodney, M.D., M.S., professor and section chief of Vascular Surgery at Dartmouth Health in New Hampshire. “For example, patients with severe disease who present at young ages have poor outcomes, irrespective of how they might be treated. This may be the result of severe disease or difficult circumstances for treatment. Either way, this information can help guide clinicians and researchers in determining the best treatments for these high-risk individuals. Similarly, the study also shows that older patients with moderate to severe disease can have good results when trying to prevent an amputation. Overall, these findings make it clear – in treatment for PAD, it is not ‘one size fits all.’”

This analysis had several limitations that may have affected the results. The data review did not account for subsequent surgeries to restore blood flow after the initial surgery; it could not account for disease severity or whether amputation occurred on the leg that underwent the initial surgery or the other leg; and race or ethnicity was not considered due to unreliable information from the database.

Study details and background:

  • The data review included 94,690 people with peripheral artery disease who underwent surgery to restore blood flow to the lower limbs between April 2013 and March 2020 in England.
  • Participants were ages 50 and older, the median age was 72 years and 66% of participants were men. 
  • Data was collected from the Hospital Episode Statistics Admitted Patient Care database in England.
  • A statistical model was created from the data to describe patterns of survival after an initial lower limb revascularization; if and when patients experienced major amputation; and survival after amputation.
  • In total, 10.0% patients underwent major amputation during the follow-up period, which ended in March 2021. Of these, two thirds were emergency patients at time they were admitted to the hospital, and more than half had died by the end of study.
  • The revascularization procedure was labelled elective if performed during an elective admission, and non-elective if performed during an emergency admission or after transfer from another hospital.

Co-authors, disclosures and funding sources are listed in the manuscript.

Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.

Additional Resources:

###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for a century. During 2024 - our Centennial year - we celebrate our rich 100-year history and accomplishments. As we forge ahead into our second century of bold discovery and impact, our vision is to advance health and hope for everyone, everywhere. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173

Bridgette McNeill: Bridgette.mcneill@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.